A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control

Sponsor
Pfizer (Industry)
Overall Status
Completed
CT.gov ID
NCT00134147
Collaborator
Sanofi (Industry)
1,100
121
25
9.1
0.4

Study Details

Study Description

Brief Summary

To assess the impact on glucose control by inhaled insulin in patients with type 2 diabetes who are not well controlled on 2 or more oral anti-diabetic agents

Condition or Disease Intervention/Treatment Phase
  • Drug: Inhaled Insulin
Phase 3

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A One Year, Open-Label Outpatient, Parallel Group Trial Assessing the Impact of the Availability of Inhaled Insulin (Exubera) on Glycemic Control in Patients With Type 2 Diabetes Mellitus Who Are Poorly Controlled on a Minimum of Two Oral Anti Diabetic Agents
Study Start Date :
Apr 1, 2005
Actual Study Completion Date :
May 1, 2007

Outcome Measures

Primary Outcome Measures

  1. Glycosylated hemoglobin []

Secondary Outcome Measures

  1. Percent of patients achieving good control of fasting glucose and lipids []

  2. Rate of hypoglycemia []

  3. Changes in body weight []

  4. Patient satisfaction []

  5. Safety based on adverse events reported and laboratory tests []

Eligibility Criteria

Criteria

Ages Eligible for Study:
35 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diabetes mellitus Type 2

  • Failing two or more oral anti-diabetic agents

Exclusion Criteria:
  • Asthma, COPD

  • Smoking

Contacts and Locations

Locations

Site City State Country Postal Code
1 Pfizer Investigational Site La Jolla California United States 92037
2 Pfizer Investigational Site San Diego California United States 92128
3 Pfizer Investigational Site Washington District of Columbia United States 20010
4 Pfizer Investigational Site Jacksonville Florida United States 32208
5 Pfizer Investigational Site Jacksonville Florida United States 32209
6 Pfizer Investigational Site Miami Florida United States 33136
7 Pfizer Investigational Site Columbus Georgia United States 31904
8 Pfizer Investigational Site Overland Park Kansas United States 66211
9 Pfizer Investigational Site New Orleans Louisiana United States 70121
10 Pfizer Investigational Site Baltimore Maryland United States 21230
11 Pfizer Investigational Site Charlotte North Carolina United States 28207
12 Pfizer Investigational Site Charlotte North Carolina United States 28212
13 Pfizer Investigational Site Raleigh North Carolina United States 27609
14 Pfizer Investigational Site Medford Oregon United States 97504-8491
15 Pfizer Investigational Site Hershey Pennsylvania United States 17033-0850
16 Pfizer Investigational Site Spartanburg South Carolina United States 29303
17 Pfizer Investigational Site San Antonio Texas United States 78229
18 Pfizer Investigational Site San Antonio Texas United States 78237
19 Pfizer Investigational Site Calgary Alberta Canada T2L 1K8
20 Pfizer Investigational Site Edmonton Alberta Canada T5J 3N4
21 Pfizer Investigational Site Red Deer Alberta Canada T4N 6V7
22 Pfizer Investigational Site Winnipeg Manitoba Canada R3E 3P4
23 Pfizer Investigational Site Corunna Ontario Canada N0N 1G0
24 Pfizer Investigational Site Oakville Ontario Canada L6H 3P1
25 Pfizer Investigational Site Smith Falls Ontario Canada K7A 4W8
26 Pfizer Investigational Site Charlottetown Prince Edward Island Canada C1A 5Y9
27 Pfizer Investigational Site Laval Quebec Canada H7T 2P5
28 Pfizer Investigational Site Montreal Quebec Canada H3A 1A1
29 Pfizer Investigational Site Bethune CEDEX France 62408
30 Pfizer Investigational Site Bourg En Bresse France 01012
31 Pfizer Investigational Site Bron France 69500
32 Pfizer Investigational Site Corbeil Essonnes Cedex France 91106
33 Pfizer Investigational Site La Rochelle Cedex France 17019
34 Pfizer Investigational Site Montpellier CEDEX France F-34295
35 Pfizer Investigational Site Nantes France 44000
36 Pfizer Investigational Site Roubaix France 59100
37 Pfizer Investigational Site TOURS cedex 7 France 37044
38 Pfizer Investigational Site Altenburg Germany 04600
39 Pfizer Investigational Site Aschaffenburg Germany 63739
40 Pfizer Investigational Site Bad Oeynhausen/ Volmerdingen Germany 32549
41 Pfizer Investigational Site Bad-Mergentheim Germany 97980
42 Pfizer Investigational Site Berlin Germany 10115
43 Pfizer Investigational Site Berlin Germany 12687
44 Pfizer Investigational Site Berlin Germany 14057
45 Pfizer Investigational Site Delmenhorst Germany 27753
46 Pfizer Investigational Site Dresden Germany 01219
47 Pfizer Investigational Site Ebersdorf Germany 96237
48 Pfizer Investigational Site Eisenach Germany 99817
49 Pfizer Investigational Site Falkensee Germany 14612
50 Pfizer Investigational Site Furth im Wald Germany 93437
51 Pfizer Investigational Site Hamburg Germany 21073
52 Pfizer Investigational Site Hamburg Germany 22391
53 Pfizer Investigational Site Hassloch Germany 67454
54 Pfizer Investigational Site Kuenzing Germany 94550
55 Pfizer Investigational Site Leipzig Germany 04103
56 Pfizer Investigational Site Meissen Germany 01662
57 Pfizer Investigational Site Mittweida Germany 09648
58 Pfizer Investigational Site Muenster Germany 48145
59 Pfizer Investigational Site Muenster Germany 48153
60 Pfizer Investigational Site Offenbach Germany 63065
61 Pfizer Investigational Site Offenburg Germany 77654
62 Pfizer Investigational Site Oschatz Germany 04758
63 Pfizer Investigational Site Pirna Germany 01796
64 Pfizer Investigational Site Riedlhuette Germany 94566
65 Pfizer Investigational Site Riesa Germany 01587
66 Pfizer Investigational Site Rossach Germany 96269
67 Pfizer Investigational Site Schwabenheim Germany 55270
68 Pfizer Investigational Site St.Ingbert Germany 66386
69 Pfizer Investigational Site Surwold Germany 26903
70 Pfizer Investigational Site Wangen / Allgaeu Germany 88239
71 Pfizer Investigational Site Wangen Germany 88239
72 Pfizer Investigational Site Witten Germany 58455
73 Pfizer Investigational Site Bari Italy 70124
74 Pfizer Investigational Site Catania Italy 95122
75 Pfizer Investigational Site Firenze Italy 50134
76 Pfizer Investigational Site Genova Italy 16132
77 Pfizer Investigational Site Milano Italy 20132
78 Pfizer Investigational Site Napoli Italy 80131
79 Pfizer Investigational Site Padova Italy 35128
80 Pfizer Investigational Site Palermo Italy 90127
81 Pfizer Investigational Site Pescara Italy 65100
82 Pfizer Investigational Site Pisa Italy 56124
83 Pfizer Investigational Site Roma Italy 00133
84 Pfizer Investigational Site Torino Italy 10126
85 Pfizer Investigational Site Udine Italy 33100
86 Pfizer Investigational Site Verona Italy 37126
87 Pfizer Investigational Site Badalona Barcelona Spain 08916
88 Pfizer Investigational Site Las Palmas Las Palmas de Gran Canaria Spain 35010
89 Pfizer Investigational Site Baracaldo Vizcaya Spain 48903
90 Pfizer Investigational Site Bilbao Vizcaya Spain 48013
91 Pfizer Investigational Site Barcelona Spain 08003
92 Pfizer Investigational Site Barcelona Spain 08017
93 Pfizer Investigational Site Barcelona Spain 08036
94 Pfizer Investigational Site Cadiz Spain 11009
95 Pfizer Investigational Site Gerona Spain 17007
96 Pfizer Investigational Site Granada Spain 18012
97 Pfizer Investigational Site Madrid Spain 28034
98 Pfizer Investigational Site Madrid Spain 28040
99 Pfizer Investigational Site Sevilla Spain 41014
100 Pfizer Investigational Site Valencia Spain 46017
101 Pfizer Investigational Site Ayr Ayrshire United Kingdom KA7 1BJ
102 Pfizer Investigational Site Thornhill Cardiff United Kingdom CF14 9BB
103 Pfizer Investigational Site Penzance Cornwall United Kingdom TR18 4JH
104 Pfizer Investigational Site St. Austell Cornwall United Kingdom PL26 7RL
105 Pfizer Investigational Site Truro Cornwall United Kingdom TR1 3LJ
106 Pfizer Investigational Site Plymouth Devon United Kingdom PL6 8BX
107 Pfizer Investigational Site Letchworth Hertfordshire United Kingdom SG6 4UB
108 Pfizer Investigational Site Sidcup Kent United Kingdom DA14 6LT
109 Pfizer Investigational Site Whitstable Kent United Kingdom CT5 3QU
110 Pfizer Investigational Site Blackpool Lancashire United Kingdom FY3 7EN
111 Pfizer Investigational Site Colney Norwich United Kingdom NR4 7UY
112 Pfizer Investigational Site Headington Oxford United Kingdom OX3 7LJ
113 Pfizer Investigational Site Penarth South Glamorgan United Kingdom CF64 2XX
114 Pfizer Investigational Site Dundee Tayside United Kingdom DD1 9SY
115 Pfizer Investigational Site Haywards Heath West Sussex United Kingdom RH16 4EX
116 Pfizer Investigational Site Birmingham United Kingdom B9 5SS
117 Pfizer Investigational Site Bolton United Kingdom BL3 6TL
118 Pfizer Investigational Site Canterbury United Kingdom CT1 3HX
119 Pfizer Investigational Site Liverpool United Kingdom L7 8XP
120 Pfizer Investigational Site Salford United Kingdom M6 8HD
121 Pfizer Investigational Site York United Kingdom YO31 8HE

Sponsors and Collaborators

  • Pfizer
  • Sanofi

Investigators

  • Study Director: Pfizer CT.gov Call Center, Pfizer

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00134147
Other Study ID Numbers:
  • A2171018
First Posted:
Aug 24, 2005
Last Update Posted:
Apr 17, 2008
Last Verified:
Apr 1, 2008
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 17, 2008